Heart Failure With Preserved Ejection Fraction: Prevention and Management

被引:13
|
作者
Cilia, Lindsey [1 ,2 ]
Saeed, Anum [1 ,2 ]
Ganga, Harsha V. [1 ,2 ,3 ]
Wu, Wen-Chih [1 ,2 ,3 ]
机构
[1] Vet Affairs Med Ctr, Div Cardiol, Providence, RI USA
[2] Brown Univ, Dept Cardiol, Alpert Med Sch, Providence, RI 02912 USA
[3] Miriam Hosp, Ctr Cardiac Fitness, Providence, RI 02906 USA
关键词
dyspnea; mortality; outcomes; patient admission; prevention; randomized trials; LEFT-VENTRICULAR HYPERTROPHY; TYPE-2; DIABETES-MELLITUS; BODY-MASS INDEX; DIASTOLIC DYSFUNCTION; BLOOD-PRESSURE; CARDIOVASCULAR OUTCOMES; OLDER PATIENTS; ARTERIAL STIFFNESS; CHOLESTEROL LEVELS; EXERCISE CAPACITY;
D O I
10.1177/1559827617695219
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Heart failure with preserved ejection fraction (HFpEF) is a complex clinical syndrome that constitutes nearly half of all heart failure cases. Because of lack of effective pharmacological targets to improve outcomes, the emphasis of the management and prevention of HFpEF should be through control of risk factors. This review will use the framework proposed by the American Heart Association on 7 simple measures ("Life's Simple 7") that involves diet and lifestyle changes to achieve ideal cardiovascular health. These 7 measures include (1) smoking, (2) obesity, (3) exercise, (4) diet, (5) blood pressure, (6) cholesterol, and (7) glucose control, which can help control the most common comorbidities and risk factors associated with HFpEF, such as hypertension, diabetes, and obesity. Therefore, application of these 7 simple measures would be a patient-centered and cost-effective way of prevention and management of HFpEF.
引用
收藏
页码:182 / 189
页数:8
相关论文
共 50 条
  • [11] Pharmacologic Management of Heart Failure with Preserved Ejection Fraction
    Huang, Dana
    Cheng, Judy W. M.
    ANNALS OF PHARMACOTHERAPY, 2010, 44 (12) : 1933 - 1945
  • [12] Management Strategies for Heart Failure with Preserved Ejection Fraction
    Vazir, Ali
    Solomon, Scott D.
    HEART FAILURE CLINICS, 2014, 10 (04) : 591 - +
  • [13] Current Management of Heart Failure with Preserved Ejection Fraction
    Patel, Akash H.
    Natarajan, Balaji
    Pai, Ramdas G.
    INTERNATIONAL JOURNAL OF ANGIOLOGY, 2022, 31 (03) : 166 - 178
  • [14] Management of heart failure with preserved ejection fraction
    Gard, Emma
    Nanayakkara, Shane
    Kaye, David
    Gibbs, Harry
    AUSTRALIAN PRESCRIBER, 2020, 43 (01) : 12 - 17
  • [15] Treatment of Heart Failure with Preserved Ejection Fraction
    Barnes, Megan M.
    Dorsch, Michael P.
    Hummel, Scott L.
    Koelling, Todd M.
    Bleske, Barry E.
    PHARMACOTHERAPY, 2011, 31 (03): : 312 - 331
  • [16] The pathophysiology of heart failure with preserved ejection fraction
    Borlaug, Barry A.
    NATURE REVIEWS CARDIOLOGY, 2014, 11 (09) : 507 - 515
  • [17] The immunology of heart failure with preserved ejection fraction
    Smart, Charles Duncan
    Madhur, Meena S.
    CLINICAL SCIENCE, 2023, 137 (16) : 1225 - 1247
  • [18] Aging and Heart Failure with Preserved Ejection Fraction
    Larson, Kathryn F.
    Malik, Awais
    Brozovich, Frank, V
    COMPREHENSIVE PHYSIOLOGY, 2022, 12 (04) : 3813 - 3822
  • [19] Mechanisms of Exercise Intolerance in Heart Failure With Preserved Ejection Fraction
    Borlaug, Barry A.
    CIRCULATION JOURNAL, 2014, 78 (01) : 20 - 32
  • [20] Heart failure with preserved ejection fraction
    Gladden, James D.
    Linke, Wolfgang A.
    Redfield, Margaret M.
    PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY, 2014, 466 (06): : 1037 - 1053